BZ Fine Funds - BZ Fine Pharma A Fonds
356,09
EUR
-0,51
EUR
-0,14
%
NAV
Werbung
Top Holdings
| Name | ISIN | Anteil |
|---|---|---|
| McKesson Corp | US58155Q1031 | 6,10% |
| Alnylam Pharmaceuticals Inc | US02043Q1076 | 5,98% |
| AbbVie Inc | US00287Y1091 | 5,59% |
| Novartis AG Registered Shares | CH0012005267 | 5,39% |
| Roche Holding AG | CH0012032048 | 5,36% |
| Genmab AS | DK0010272202 | 5,29% |
| AstraZeneca PLC | GB0009895292 | 5,22% |
| Johnson & Johnson | US4781601046 | 4,85% |
| Vertex Pharmaceuticals Inc | US92532F1003 | 4,36% |
| H. Lundbeck AS Ordinary Shares - Class B | DK0061804770 | 4,15% |
| Sonstige | 47,72% |